Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Akebia, Amgen, Active, Aileron, Arcutis, Biohaven, Cymabay, Genmab, Immunic, Innovent, Janssen, Kadimastem, Lilly, Lipocine, Myokardia, Polyphor, Takeda.